Intesa invests 360 million euros to manage its entire health insurance business

Published Date: 08 Mar 2023

Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.

Read Full News

Latest News

Doctors Are Leaning Into Anti-Hustle Vacations

Some doctors are trading crammed itineraries for something radical on vacation: doing absolutely nothing at all.

The Market Forces Quietly Adding Thousands to Patient Bills

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

FDA Clears First Standalone Robotic Blood Draw System

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Med Students’ Secret Weapon? Sleep

Rather than cramming for med school exams all night with little sleep, med students should know that sleep is the key to better learning and memorizing new information.

Oncology Firm Novocure Says Cyberattack Exposed US Patient Records

Oncology company Novocure said on Tuesday a cybersecurity incident involving unauthorized ⁠access to certain information systems in mid-August exposed internal records of...

How the Affordability Crisis Is Hitting PAs

Rising costs are squeezing physician associates just like everyone else. How they’re reshaping their finances, career choices, and quality of life.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

Some doctors are trading crammed itineraries for something radical on vacation: doing absolutely nothing at all.

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Rather than cramming for med school exams all night with little sleep, med students should know that sleep is the key to better learning and memorizing new information.

Oncology company Novocure said on Tuesday a cybersecurity incident involving unauthorized ⁠access to certain information systems in mid-August exposed internal records of...

Rising costs are squeezing physician associates just like everyone else. How they’re reshaping their finances, career choices, and quality of life.

News All Time

CMS Proposes Major Medicare Physician Payment Overhaul to Boost Primary Care

The Centers for Medicare & Medicaid Services on Tuesday proposed changes to Medicare's decades-old physician payment system, saying the ⁠updates would support the Trump...

Married to Medicine: The Other Side of the Story

Being married to a doctor isn’t the easiest job. These doctors’ spouses share what it’s like and where to get support.

Cigna Invests $100 Million in New AI-powered Specialty Pharmacy Program

Cigna said on Wednesday its health services unit Evernorth has launched a new ⁠AI-powered specialty pharmacy program to reduce the time it takes to process prescriptions and...

Resident Doctors in England Vote for UK Government's Pay Offer, Ending Strikes

Resident doctors in England have voted to accept the government's latest pay and job offer, their ⁠union said on Monday, bringing an end to a long-running industrial dispute...

Democratic-led States Sue Over Trump Administration's Medicaid Work Requirement Rule

A coalition of Democratic-led states sued on Monday to block a Trump administration rule implementing new work requirements for Medicaid recipients, ⁠arguing it unlawfully...

Trump Cuts New York Funding for Medicaid Fraud Unit

The Trump administration said on Tuesday it would cut off funding to ⁠New York's Medicaid fraud unit, accusing it of underperforming in a move that could jeopardize the...

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Analysis-Big Pharma Taps UK Playbook to Pressure European Capitals on Drug Prices

Global pharmaceutical companies, facing pushback from European capitals on drug pricing, are turning to a playbook that brought them recent success in Britain: threats of...

Studies Confirm Private Equity Dangers

A handful of studies confirm that hospitals taken over by private equity have worse outcomes for patients.

Cholera Outbreak in Nigeria's Borno Kills 74, Infects Thousands Since May

A cholera outbreak that began in early May in Nigeria's northeastern Borno state ⁠has killed at least 74 people and infected more than 7,800, overwhelming health facilities,...

Nurses Filling Doctor Gaps: What Happens to Hard Cases?

As health systems consider shifting more physician tasks to nurses, Medscape readers focused on whether expanded care models include clear supervision, escalation, and time for patients who do not fit routine protocols.

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

More Nurses are Clocking in to Second Jobs

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

Sandoz Files European Complaint About Chinese Antibiotic Imports

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

What Your ZIP Code Is Costing You

Forget salary. The cities winning the physician satisfaction race are playing a completely different game.

Recommended News For You

Second opinions don't significantly delay breast cancer treatment

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Safe and acceptable telehealth suicide prevention program.

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

Including Bereavement in the Care Continuum.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

Recommended Articles For You

Understanding Mantle Cell Lymphoma Prognosis. 

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

Case Learning from Acquired Platelet Function Disorders 

Modern Updates in Hematology in the Digital Era 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

2.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

3.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

4.

After all, Pulled Myeloma Drug May Help Treat the Illness.

5.

Dual Checkpoint Blockade Boosts Breast Cancer pCR

1.

Mechanisms of Tumor–Stromal Communication During Cancer Progression

2.

Spatial Pharmacology Within the Tumor Microenvironment: Precision in Oncologic Therapeutics

3.

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma

4.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

5.

Circulating Tumor DNA Dynamics for Therapy Matching: A Comprehensive Clinical Review

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Recognizing the Signs of Anemia in Adults

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot